limestone has been researched along with 24,25-dihydroxyvitamin d 3 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bdolah-Abram, T; Ben-Ezer, D; Chaimovitz, C; Conforty, A; Edelstein, S; Kafka, DR; Rapoport, J; Shany, S | 1 |
1 trial(s) available for limestone and 24,25-dihydroxyvitamin d 3
| Article | Year |
|---|---|
Oral administration of 24,25(OH)2D3 suppresses the serum parathyroid hormone levels of dialysis patients.
Topics: 24,25-Dihydroxyvitamin D 3; Administration, Oral; Aged; Calcium Carbonate; Dose-Response Relationship, Drug; Humans; Kidney Failure, Chronic; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory | 1991 |